Clinical Trial Details

USOR 18128

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Prostate Cancer
Study Type: Interventional
Phase: II
Study Start Date: 05/01/2019
Study Completion Date: 02/2024

This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer.

 

NCT Number

NCT03706365

Principal Investigator(s)

John Wallmark, MD

Sponsor(s)

Eli Lilly and Company

Participant Eligibility

• Age: 18 - No Maximum
• Gender: Male, Female